Real-world monitoring costs associated with initiation of disease-modifying therapy among patients with multiple sclerosis

The requested reference [ccf04e2c3ae4075c5e211982218f8e7e48414788] no longer exists in our database. It has been replaced by the current reference: [1ab91e828b29dd031ca74299f2aafb7584bdef63]

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 3edc0018e93568b51fd5e3df37c4df6866a71015
First added on: Feb 08, 2025